Aurora Cannabis Inc
Aurora Cannabis Inc. is a Canadian cannabis company focused on the production, distribution, and sale of cannabis and cannabis-derived products in Canada and international markets. Aurora Cannabis Inc. serves both medical and consumer segments with offerings that include pharmaceutical-grade cannabis, dried flower, oils, capsules, concentrates, and other product formats designed for adult-use and therapeutic applications. The company operates through cannabis and plant propagation businesses, supporting a portfolio that spans branded consumer products, medical cannabis channels, and agricultural propagation activities. Headquartered in Edmonton, Alberta, Aurora Cannabis Inc. plays a notable role in the regulated cannabis industry by supplying patients, consumers, and wholesale partners across multiple regions.
$3.99
-$0.11 (-2.68%)
EOD Oct 16, 2026
The business is unprofitable at the operating level (-14.55% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 6.6% YoY. Margins deteriorated 17.5pp alongside, both lines moving the wrong way.
ROIC dropped from 1.09% to -5.90%, capital efficiency is deteriorating. Negative free cash flow of -C$36M. The business is consuming cash, not generating it.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
C$290M
▼ -6.6% YoY
Net Income (TTM)
-C$120M
▼ -8645.8% YoY
Op. Margin
-12.01%
▼ -17.5pp YoY
ROIC
-5.90%
▼ -7.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-C$51M
▼ -1163.3% YoY
Op. Cash Flow (TTM)
-C$28M
▼ -155.9% YoY
Net Debt
-C$93M
Net Cash Position
Cash & Equiv.
C$117M
3Y CAGR: +13.1%
Continue Research
Is Aurora Cannabis (ACB) overvalued?
Aurora Cannabis (ACB)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Aurora Cannabis scores 36/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is Aurora Cannabis a high-quality business?+
Aurora Cannabis scores 36 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -12.0% operating margin and a -5.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Aurora Cannabis a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh ACB's valuation and scores 36/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.
Related stocks: Drug Manufacturers - Specialty & Generic
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.